礼来公司最新通告显示，其减肥药物Zepbound现已全面开放所有剂量规格的供应选项。患者可根据个人需求，灵活选择多剂量Kwikpen注射笔或单剂量小瓶两种包装形式。
值得注意的是，2.5毫克基础剂型的月治疗费用门槛已降至299美元，这为更多患者提供了可负担的治疗方案。此次供应方式的拓展将有效提升用药便利性，满足不同患者的个性化医疗需求。
礼来公司最新通告显示，其减肥药物Zepbound现已全面开放所有剂量规格的供应选项。患者可根据个人需求，灵活选择多剂量Kwikpen注射笔或单剂量小瓶两种包装形式。
值得注意的是，2.5毫克基础剂型的月治疗费用门槛已降至299美元，这为更多患者提供了可负担的治疗方案。此次供应方式的拓展将有效提升用药便利性，满足不同患者的个性化医疗需求。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.